Last updated: 16 June 2019 at 4:55am EST

European Investment Co Llcc... Net Worth




The estimated Net Worth of European Investment Co Llcc... is at least $44.4 Million dollars as of 29 April 2014. European Llcc owns over 294,800 units of Agios Pharmaceuticals Inc stock worth over $44,448,823 and over the last 11 years European sold AGIO stock worth over $0.

European Llcc AGIO stock SEC Form 4 insiders trading

European has made over 2 trades of the Agios Pharmaceuticals Inc stock since 2013, according to the Form 4 filled with the SEC. Most recently European bought 294,800 units of AGIO stock worth $12,971,200 on 29 April 2014.

The largest trade European's ever made was buying 708,333 units of Agios Pharmaceuticals Inc stock on 29 July 2013 worth over $12,749,994. On average, European trades about 501,567 units every 137 days since 2013. As of 29 April 2014 European still owns at least 1,003,133 units of Agios Pharmaceuticals Inc stock.

You can see the complete history of European Llcc stock trades at the bottom of the page.



What's European Llcc's mailing address?

European's mailing address filed with the SEC is 86 MORRIS AVENUE86 MORRIS AVENUE86 MORRIS AVENUE, , SUMMITSUMMITSUMMIT, NJNJNJ, 079010790107901.

Insiders trading at Agios Pharmaceuticals Inc

Over the last 11 years, insiders at Agios Pharmaceuticals Inc have traded over $77,887,085 worth of Agios Pharmaceuticals Inc stock and bought 3,229,562 units worth $154,554,190 . The most active insiders traders include Kevin P Starr, Robert Nelsen, and John Maraganore. On average, Agios Pharmaceuticals Inc executives and independent directors trade stock every 9 days with the average trade being worth of $765,588. The most recent stock trade was executed by Rahul D. Ballal on 11 August 2024, trading 2,302 units of AGIO stock currently worth $102,002.



What does Agios Pharmaceuticals Inc do?

at agios, we are doing incredibly important and difficult work. we are trying to discover and develop breakthrough medicines, and we have a clear motivator — people with cancer and rare genetic diseases who are counting on us to be successful. we are a science-driven research organization. we have built a discovery platform upon our expertise in the fields of cellular metabolism and precision medicine across three major focus areas: cancer metabolism, rare genetic metabolic disorders and metabolic immuno-oncology. it takes people with a diversity of thought, skills, passions and backgrounds to get us from the first stages of understanding new biology and discovering drugs to our ultimate goal of getting these medicines to patients who are waiting for them. our connection to one another and our work and our commitment to our values enable us to potentially change the practice of medicine by by striving for excellence and doing things differently. we call this the "other side of possible



What does Agios Pharmaceuticals Inc's logo look like?

Agios Pharmaceuticals Inc logo

Complete history of European Llcc stock trades at Agios Pharmaceuticals Inc

Date
#
Company
Insider
Trans.
Transaction
Shares Price per share Total value Shares after Source
29 Apr 2014 European Investment Co Llcc...
Buy 294,800 $44.00 $12,971,200
29 Apr 2014
1,003,133
29 Jul 2013 European Investment Co Llcc...
Buy 708,333 $18.00 $12,749,994
29 Jul 2013
708,333


Agios Pharmaceuticals Inc executives and stock owners

Agios Pharmaceuticals Inc executives and other stock owners filed with the SEC include: